Market Research Logo

India Pharmaceuticals and Healthcare Report Q2 2016

India Pharmaceuticals and Healthcare Report Q2 2016

BMI View: The shift in the pharmaceutical landscape due to the Trans-Pacific Partnership (TPP) will benegative for the Indian generic drug industry. Collectively accounting for 40% of medicine exports fromIndia, the 12 member markets of the TPP will see stronger patent protection and longer regulatory dataprotection. This coupled with the introduction of a patent linkage system will serve to deter the introductionof Indian generic drugs and curtail their overall growth.

Headline Expenditure Projections

Pharmaceuticals: INR1,066bn (USD16bn) in 2015 to INR1,191bn (17bn) by 2016; +11.7% in localcurrency terms and 6.4% in US dollar terms.

Healthcare: INR5,716bn (USD88bn) in 2015 to INR6,395bn (USD94bn) by 2016; +11.9% in localcurrency terms and 6.6% in US dollar terms.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (India 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (India 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (India 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (India 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (India 2012-2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (India 2012-2020)
Patented Drug Market Forecast
Table: Selected Patent Developments Affecting Drugmakers
Table: Patented Drug Market Indicators, Historical Data And Forecasts (India 2012-2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (India 2012-2020)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (India 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (India 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (India 2014-2020)
Industry Risk Reward Index
Asia Pacific Risk/Reward Index
India Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Issues
Table: History Of The Indian Patent System
Table: A Series Of Setbacks For Innovative Pharmaceutical Firms
Pricing Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (India 2010-2015)
Table: Healthcare Personnel (India 2010-2015)
Table: Healthcare Activity (India 2010-2015)
Clinical Trials
Epidemiology
Table: Estimated Number Of New Cases Of Cancer In India
Competitive Landscape
Research-Based Industry
Table: Ordinary Members Of OPPI
Table: Multinational Market Activity
Generic Drug Industry
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
Aurobindo Pharmaceutical
Cipla
Dr. Reddy's Laboratories
GlaxoSmithKline
Merck & Co
Novartis
Pfizer
Sanofi India
Sun Pharmaceutical
Demographic Forecast
Table: Population Headline Indicators (India 1990-2025)
Table: Key Population Ratios (India 1990-2025)
Table: Urban/Rural Population & Life Expectancy (India 1990-2025)
Table: Population By Age Group (India 1990-2025)
Table: Population By Age Group % (India 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report